Role of body size on cardiovascular function: Can we see the meat through the fat?

Hypertension

Volumn 54, Issue 3, 2009, Pages 459-461

  Chantler, Paul D ^a   Lakatta, Edward G ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ATHEROSCLEROSIS; BODY FAT; BODY MASS; BODY SIZE; BODY SURFACE; BODY WEIGHT; CARDIOVASCULAR FUNCTION; ENERGY METABOLISM; FATTY ACID METABOLISM; GLUCONEOGENESIS; HEART DISEASE; HEART MUSCLE; IMMUNE FUNCTION TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; SKELETAL MUSCLE; ARTERY; HEART; HEART VENTRICLE; HEMODYNAMICS; HUMAN; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ARTERIES; BODY MASS INDEX; BODY SIZE; HEART; HEART VENTRICLES; HEMODYNAMICS; HUMANS; MIDDLE AGED; OBESITY;

EID: 70349248015     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.134452     Document Type: Note

References (11)

1. Chirinos J, Rietzschel E, De Buyzere M, De Bacquer D, Gillebert T, Gupta A, Segers P. Arterial load and ventricular-arterial coupling: physiologic relations with body size and effect of obesity. Hypertension. 2009;54:558-566.
2. O'Connor F, Fleg JL, Gerstenblith G, Becker LC, Goldberg AP, Hagberg JM, Lakatta L, Lakatta EG, Schulman SP. Effect of body fat on exercise hemodynamics in sedentary older men. Aging. 1994;6:257-265.
3. Batterham AM, George KP, Whyte G, Sharma S, McKenna W. Scaling cardiac structural data by body dimensions: a review of theory, practice, and problems. Int J Sports Med. 1999;20:495-502.
4. Rasouli N, Kern PA. Adipocytokines and the Metabolic Complications of Obesity. J Clin Endocrinol Metab. 2008;93:s64-s73.
5. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002;51:3391-3399.
6. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, Sauerwein HP. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol. 1995;268:E813-E819.
7. Cartier A, Lemieux I, Almeras N, Tremblay A, Bergeron J, Despres JP. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab. 2008;93:1931-1938.
8. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation. 2009; 119:1661-1670.
9. Fox CS, Gona P, Hoffmann U, Porter SA, Salton CJ, Massaro JM, Levy D, Larson MG, D'Agostino RB Sr, O'Donnell CJ, Manning WJ. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation. 2009; 119:1586-1591.
10. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 2008;52:1793-1799.
11. van der Meer RW, Rijzewijk LJ, Diamant M, Hammer S, Schar M, Bax JJ, Smit JW, Romijn JA, de Roos A, Lamb HJ. The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J. 2008;29:1516-1522.